Researchers at Cedars-Sinai have found something unexpected in the retinas of Alzheimer's patients: a bacterium best known for causing pneumonia and sinus infections. The discovery, published in Nature Communications, suggests that Chlamydia pneumoniae — a common respiratory pathogen — may play a role in brain degeneration, and that the eye could become a window for detecting the disease early.
The study examined retinal tissue from 104 people across three groups: those with normal cognition, mild cognitive impairment, and Alzheimer's disease. Researchers found significantly higher levels of the bacterium in both the retinas and brains of people with Alzheimer's compared to those with normal cognition. More striking: the bacterial load tracked closely with the severity of brain changes and cognitive decline. In other words, more bacteria correlated with worse outcomes.
A Window Into Brain Health
Why the retina matters is crucial here. It's part of the central nervous system — essentially an extension of the brain — but unlike brain tissue, it can be examined without surgery. This makes it a rare opportunity to observe brain-related biology in living patients. The research team used advanced imaging alongside genetic and protein analysis to detect the bacteria and trace its effects. When Chlamydia pneumoniae settled in retinal tissue, it triggered immune activity linked to inflammation, nerve cell death, and cognitive decline.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxGenetics appeared to amplify the risk. People carrying the APOE4 gene variant — already known to increase Alzheimer's susceptibility — were more likely to have higher bacterial levels in their eyes and brains.
Laboratory work reinforced the connection. When researchers infected human neurons in culture and laboratory mice with the bacterium, it accelerated the hallmarks of Alzheimer's: increased inflammation, nerve cell death, and cognitive decline. The infection also triggered production of amyloid-beta, the protein that accumulates in Alzheimer's brains.
"The eye is a surrogate for the brain," said Maya Koronyo-Hamaoui, the study's senior author. This insight opens two possibilities. First, retinal imaging could become a noninvasive screening tool — a way to identify people at risk before symptoms appear. Second, targeting the bacterial infection and the inflammation it triggers might offer a new treatment angle, one that shifts focus from the proteins that accumulate in Alzheimer's to the infection-inflammation axis that may accelerate their buildup.
The research doesn't claim Chlamydia pneumoniae causes Alzheimer's outright. Rather, it suggests the bacterium — which can persist for years in the body — may be one factor among many that tips the scale toward neurodegeneration in people already genetically vulnerable. That distinction matters, because it points toward interventions that might prevent or slow disease in at-risk populations.
